HomeTrialNCT07090161
🔬NCT07090161Phase 2RECRUITING

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

Study Summary

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment240 participants
Primary Completion
Lead SponsorVanda Pharmaceuticals
Data Retrieved2026-04-11 04:31:05.188736+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.